Concepedia

Aradhana Rani

AR

Statistics

Publications

7

Citations

229

H-Index

7

Active since

2011

Affiliations

King's College London(Current)

Royal Marsden Hospital

Institute of Cancer Research

Breast Cancer Now

Guy's Hospital

Aradhana Rani is an author at King's College London specializing in medicine, signal transduction, and pharmacology.

ORCID

Publications per year

2011–2021

7

Publications

7

AKT Antagonist AZD5363 Influences Estrogen Receptor Function in Endocrine-Resistant Breast Cancer and Synergizes with Fulvestrant (ICI182780) <i>In Vivo</i>

Ricardo Ribas, Sunil Pancholi, Stephanie K. Guest et al. · Molecular Cancer Therapeutics · 2015 · 72 citations

, , +17

IL-15 Upregulates Telomerase Expression and Potently Increases Proliferative Capacity of NK, NKT-Like, and CD8 T Cells

Fiona Watkinson, Sandeep Krishan Nayar, Aradhana Rani et al. · Frontiers in Immunology · 2021 · 45 citations · Full text

, , +17

IL-2 Regulates Expression of <i>C-MAF</i> in Human CD4 T Cells

Aradhana Rani, Behdad Afzali, Audrey Kelly et al. · The Journal of Immunology · 2011 · 28 citations · Full text

, , +17

Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor–positive breast cancers

Ricardo Ribas, Zara Ghazoui, Qiong Gao et al. · Breast Cancer Research · 2014 · 26 citations · Full text

, , +17

Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer

Ricardo Ribas, Sunil Pancholi, Aradhana Rani et al. · Breast Cancer Research · 2018 · 26 citations · Full text

, , +17

1–5 of 7